Biomedical engineers from The Johns Hopkins University have partnered with clinicians to create new therapeutic eye injections for a type of central vision loss caused by blood vessel growth at the back of the eye.
The new drug, with a biodegradable time-release coating is currently being tested to evaluate effectiveness in stopping such growth in mice.